Stockscreener 앱 받기
31.89
0.57%
0.18
전일 마감가:
$31.71
열려 있는:
$31.6
하루 거래량:
2.31M
Relative Volume:
1.11
시가총액:
$5.06B
수익:
$264.79M
순이익/손실:
$-14.36M
주가수익비율:
-289.91
EPS:
-0.11
순현금흐름:
$-28.11M
1주 성능:
+10.12%
1개월 성능:
+11.04%
6개월 성능:
-10.47%
1년 성능:
+44.43%
1일 변동 폭
$30.85
$32.08
1주일 범위
$28.61
$33.40
52주 변동 폭
$21.11
$46.48
TG테라퓨틱스사 Stock (TGTX) Company Profile
명칭
Tg Therapeutics Inc
전화
(212) 554-4484
주소
2 GANSEVOORT STREET, 9TH FLOOR, NEW YORK, NY
TGTX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TGTX
Tg Therapeutics Inc
|
31.89 | 4.72B | 264.79M | -14.36M | -28.11M | -0.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
TG테라퓨틱스사 Stock (TGTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-10 | 재개 | Goldman | Neutral |
| 2024-10-29 | 개시 | TD Cowen | Buy |
| 2023-08-02 | 업그레이드 | Goldman | Sell → Neutral |
| 2023-06-26 | 재개 | Jefferies | Buy |
| 2022-05-20 | 개시 | BofA Securities | Underperform |
| 2022-02-23 | 재확인 | B. Riley Securities | Buy |
| 2021-11-15 | 다운그레이드 | Goldman | Neutral → Sell |
| 2021-04-20 | 개시 | Goldman | Neutral |
| 2021-04-19 | 재확인 | H.C. Wainwright | Buy |
| 2020-09-01 | 개시 | JP Morgan | Overweight |
| 2020-08-11 | 재확인 | H.C. Wainwright | Buy |
| 2020-06-05 | 개시 | Evercore ISI | Outperform |
| 2020-01-17 | 재확인 | H.C. Wainwright | Buy |
| 2019-11-27 | 재개 | B. Riley FBR | Buy |
| 2019-02-06 | 재개 | Jefferies | Buy |
| 2018-09-25 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2018-03-09 | 재확인 | B. Riley FBR, Inc. | Buy |
| 2017-12-01 | 재개 | B. Riley FBR, Inc. | Buy |
| 2017-11-14 | 재개 | H.C. Wainwright | Buy |
| 2017-04-25 | 개시 | Jefferies | Buy |
| 2017-03-06 | 재확인 | FBR & Co. | Outperform |
| 2016-10-06 | 재개 | Brean Capital | Buy |
| 2016-05-27 | 개시 | SunTrust | Buy |
| 2015-12-01 | 개시 | FBR Capital | Outperform |
| 2015-09-09 | 개시 | Raymond James | Strong Buy |
| 2015-08-12 | 재개 | H.C. Wainwright | Buy |
| 2015-06-19 | 재확인 | Brean Capital | Buy |
| 2014-12-11 | 재확인 | ROTH Capital | Buy |
| 2014-12-10 | 재확인 | ROTH Capital | Buy |
모두보기
TG테라퓨틱스사 주식(TGTX)의 최신 뉴스
Published on: 2025-09-05 02:02:16 - Newser
What recovery options are there for TG Therapeutics Inc.2025 Market Outlook & Daily Stock Momentum Reports - Newser
Is TG Therapeutics Inc. stock reversal real or fake2025 Biggest Moves & Daily Risk Controlled Trade Plans - Newser
Real time social sentiment graph for TG Therapeutics IncWeekly Risk Summary & Precise Buy Zone Tips - Newser
What’s the recovery path for long term holders of TG Therapeutics Inc.Trade Risk Report & Daily Profit Maximizing Tips - Newser
Sector ETF performance correlation with TG Therapeutics Inc.Market Risk Analysis & Low Risk High Reward Trade Ideas - Newser
TG Therapeutics CEO to Participate in H.C. Wainwright Global Investment Conference. - AInvest
TG Therapeutics to Participate in the H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewswire
TG Therapeutics: Strategic Innovations and Market Expansion as Catalysts for Investor Optimism - AInvest
Should you wait for a breakout in TG Therapeutics Inc.2025 Market Trends & Risk Adjusted Swing Trade Ideas - Newser
How institutional ownership impacts TG Therapeutics Inc. stockQuarterly Market Summary & Weekly Stock Breakout Alerts - Newser
Will TG Therapeutics Inc. bounce back from current support2025 Volume Leaders & Free High Return Stock Watch Alerts - Newser
Will TG Therapeutics Inc. stock go up in YEARTrade Volume Report & Free Growth Oriented Trading Recommendations - khodrobank.com
What to do if you’re stuck in TG Therapeutics Inc.2025 Big Picture & Capital Efficiency Focused Ideas - Newser
Technical analysis overview for TG Therapeutics Inc. stockJuly 2025 Snapshot & AI Forecasted Stock Moves - Newser
Can TG Therapeutics Inc. stock outperform in a bear marketDividend Hike & Weekly Breakout Opportunity Watchlist - khodrobank.com
TG Therapeutics (NASDAQ:TGTX) shareholder returns have been fantastic, earning 411% in 3 years - simplywall.st
TG Therapeutics at Cantor Conference: Strategic Growth Insights - Investing.com
Tg Therapeutics shares rise 5.08% intraday after completing a $100 million share repurchase program. - AInvest
TG Therapeutics launches $100M share buybacks (TGTX:NASDAQ) - Seeking Alpha
TG Therapeutics CEO Voices Strong Conviction In Briumvi With New $100 Million Buyback - uk.finance.yahoo.com
Why Is TG Therapeutics (TGTX) Up 4.7% Since Last Earnings Report? - uk.finance.yahoo.com
Tg Therapeutics shares rise 8.36% intraday after completing $100M stock buyback and authorizing new $100M plan. - AInvest
Using data tools to time your TG Therapeutics Inc. exit2025 Year in Review & Fast Gain Stock Trading Tips - Newser
Ranking TG Therapeutics Inc. among high performing stocks via toolsMarket Risk Summary & Stepwise Trade Execution Plans - Newser
TG Therapeutics Announces Completion of Existing Share - GlobeNewswire
TG Therapeutics, Inc. authorizes a Buyback Plan. - MarketScreener
Tranche Update on TG Therapeutics, Inc.'s Equity Buyback Plan announced on August 6, 2024. - MarketScreener
TG Therapeutics, Inc. announces an Equity Buyback for $100 million worth of its shares. - MarketScreener
How cyclical is TG Therapeutics Inc.’s revenue streamMarket Movers & Verified Swing Trading Watchlists - khodrobank.com
TG Therapeutics Board Authorizes New $100M Share Repurchase Program - Stocktwits
TG Therapeutics’ $100M Share Buyback and Strategic Position in the Anti-CD20 Market - AInvest
TG Therapeutics completes $100 million share buyback, approves new program - Investing.com
TG Therapeutics Announces Completion of Existing Share Repurchase Program and Authorization of New $100 Million Program | TGTX Stock News - GuruFocus
TG Therapeutics Launches New $100 Million Share Buyback Program - MarketScreener
TG Therapeutics Completes $100 Million Share Repurchase Program and Authorizes New $100 Million Repurchase Initiative - Quiver Quantitative
TG Therapeutics completes $100 mln share repurchase program, announces new $100 mln authorization. - AInvest
TG Therapeutics Inc.’s volatility index tracking explainedJuly 2025 Snapshot & Reliable Intraday Trade Alerts - Newser
TG Therapeutics Completes $100M Share Repurchase Program, Authorizes New $100M Program - AInvest
$100M Buyback Complete: TG Therapeutics Doubles Down with Fresh $100M Share Repurchase Authorization - Stock Titan
Sentiment analysis tools applied to TG Therapeutics Inc.July 2025 Momentum & Entry and Exit Point Strategies - Newser
Using fundamentals and technicals on TG Therapeutics Inc2025 Analyst Calls & Weekly Watchlist of Top Performers - Newser
Analyzing net buyer seller activity in TG Therapeutics Inc.Weekly Trend Recap & Community Trade Idea Sharing - Newser
Can TG Therapeutics Inc. outperform in the next rallyJuly 2025 Movers & Low Risk Growth Stock Ideas - khodrobank.com
Is it too late to sell TG Therapeutics Inc.July 2025 Technicals & Entry Point Strategy Guides - Newser
Using fundamentals and technicals on TG Therapeutics Inc.Quarterly Growth Report & Technical Buy Zone Confirmations - Newser
Why TG Therapeutics Inc. is moving todayBreakout Watch & Daily Chart Pattern Signal Reports - Newser
How to manage a losing position in TG Therapeutics Inc.Portfolio Profit Report & Fast Moving Stock Watchlists - Newser
What is TG Therapeutics Inc.’s market positionQuarterly Portfolio Summary & Verified Trade Idea Suggestions - khodrobank.com
Using Python tools to backtest TG Therapeutics Inc. strategiesTrade Volume Summary & Fast Exit and Entry Trade Guides - Newser
Merger Talk: Is TG Therapeutics Inc. currently under institutional pressure2025 Market WrapUp & Verified High Yield Trade Plans - khodrobank.com
TG테라퓨틱스사 (TGTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.75%
1.11%
자본화:
|
볼륨(24시간):